RobertSaltrick
Director
Rob is an investment professional with a background in accounting and corporate finance.
Having joined GHO in 2017, Rob currently works closely with the management teams at Validant and X-Chem, having previously also supported on GHO’s investment in Ardena.
Prior to GHO, he was an Assistant Manager in the Corporate Finance team at Deloitte, where he worked on a range of corporate valuations. Rob started his career at PKF, auditing mid-market companies.
Rob graduated from Manchester University with a first-class degree in Business Management and is a Chartered Accountant.
Board Seats
ELIQUENT Life Sciences
ELIQUENT Life Sciences
Current
ELIQUENT (formerly Validant) is a leading international provider of quality compliance and regulatory affairs consulting services to biotech, pharma and medtech companies.